Entwicklung einer maßgeschneiderten Intervention (Tailoring) am Beispiel der Implementierung von Empfehlungen zur Polypharmakotherapie bei multimorbiden Patienten (PomP)

Translated title of the contribution: Developing a tailored intervention: Implementing recommendations for polypharmacy in multimorbid patients (PomP)

Cornelia Jäger*, Joachim Szecsenyi, Tobias Freund, Johanna Katharina Reichel, Christina Kuhlmey, Michel Wensing, Jost Steinhäuser

*Corresponding author for this work
6 Citations (Scopus)

Abstract

Introduction Implementation research deals with the question of how to ensure that evidence-based knowledge is put into practice. One approach is the development of "tailored interventions (TI)". These are designed to address previously identified barriers and enablers. A common definition or methodological concept for TI has not yet been established. In this paper, a concept for TI is introduced. We describe the stepwise development of an implementation intervention for GP settings where recommendations based on current evidence are provided for the treatment of multimorbid patients receiving polypharmacy. Each step will be explained and illustrated by original data. Methods / Results A stepwise approach was used to develop a TI: problem analysis, identification and prioritisation of determinants, identification and prioritisation of strategies and the design of a complex intervention and its underlying logic model. Discussion The stepwise exemplary description of this tailoring strategy may support other researchers in this field when designing a TI.

Translated title of the contributionDeveloping a tailored intervention: Implementing recommendations for polypharmacy in multimorbid patients (PomP)
Original languageGerman
JournalZeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
Volume108
Issue number5-6
Pages (from-to)270-277
Number of pages8
ISSN1865-9217
DOIs
Publication statusPublished - 01.01.2014

Fingerprint

Dive into the research topics of 'Developing a tailored intervention: Implementing recommendations for polypharmacy in multimorbid patients (PomP)'. Together they form a unique fingerprint.

Cite this